As neurotech research and innovation continues to advance, photobiomodulation (PBM) using infrared light shines through as a promising solution for athletic performance and general health. This week, the Wall Street Journal featured Vielight as a leader in this emerging field, with a well-researched story that touched on some applications for photobiomodulation among elite athletes [...]
Middle school biology imparts a well-remembered fact: mitochondria are the cellular powerhouses responsible for energy production. But recent scientific findings suggest that mitochondria may also hold the key to preserving our memories and combating Alzheimer's disease. This article explores the emerging role of mitochondria in Alzheimer's disease, highlighting scientific research and offering insights into [...]
Brain Photobiomodulation: A Drug-Free Alternative for Treating Alzheimer's Disease Alzheimer's disease, a progressive neurodegenerative disorder, poses one of the greatest challenges to modern medicine. With its devastating impact on cognitive function and quality of life, finding effective treatments has become an urgent priority. As traditional pharmacological therapies struggle to provide a definitive cure, alternative [...]
Chronic traumatic encephalopathy (CTE) is a degenerative brain disease that is believed to result from repeated head injuries, particularly concussions. It is commonly associated with contact sports such as football, hockey, boxing, and rugby, but can also occur in other activities that involve repeated blows to the head. CTE is characterized by the accumulation [...]
The Vielight Neuro Gamma was utilized in a study examining the link between creativity and brain photobiomodulation, specifically of the Default Mode Network. This groundbreaking study had 58 healthy participants and was sham-controlled, single-blinded and randomized. Researchers from the University of Deusto, Spain, the University of Montpellier, France and Pennsylvania State University, USA were [...]
The Ongoing Search for Effective and Accessible Treatments for Alzheimer’s Disease Alzheimer’s disease (AD) is the most common type of dementia in elderly individuals worldwide (Wilson et al., 2012). The disease is characterized by neurodegeneration, tissue changes in the brain, (including amyloid-containing plaques and tangles of hyperphosphorylated tau protein), severe cognitive decline and in [...]
Approval from Canada’s Top Federal Health Agency Followed Positive Clinical Trial Results We are honored to announce that the Vielight RX Plus device has received medical device approval from Health Canada! We conducted an n=295 clinical trial for Covid-19 recovery for which the results were statistically significant. This represents [...]
Photobiomodulation (PBM) therapy involves using non-thermal light, specifically narrow-wavelength bands of red and near-infrared light from LED or laser sources, to affect cellular responses. This therapy primarily targets cytochrome-C-oxidase, which releases reactive oxygen species (ROS) and regulates cellular signaling pathways. PBM therapy has a strong safety record and is free of serious side-effects, making [...]
At the moment, there are no pharmacological treatments for Autism Spectrum Disorder (ASD) core features. There is a growing interest in non-pharmacological interventions for ASD, such as neuromodulation with brain photobiomodulation 🧠 Dr Pallanti Stefano, a Stanford University Professor and Director of Istituto di Neuroscienze, Florence, Italy, led an independent retrospective study with the Vielight [...]
In 2015, our dementia pilot trial made history by being the first to show efficacy of brain photobiomodulation (PBM) for dementia in humans with a home-use device.[1] In 2019, Dr. Linda Chao, a professor in the Departments of Radiology, Biomedical Imaging and Psychiatry at the University of California, verified our 2015 dementia pilot trial [...]
